Log In
Print this Print this

concizumab (mAb2021)

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
Description mAb against Tissue Factor Pathway Inhibitor (TFPI)
Molecular Target Tissue factor pathway inhibitor (TFPI) (LACI)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A and B
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today